D
Davide Stolfo
Researcher at University of Trieste
Publications - 145
Citations - 4163
Davide Stolfo is an academic researcher from University of Trieste. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 19, co-authored 93 publications receiving 1505 citations. Previous affiliations of Davide Stolfo include Cardiovascular Institute of the South & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?]
Journal ArticleDOI
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Martin Ortiz-Genga,Sofía Cuenca,Matteo Dal Ferro,Esther Zorio,Ricardo Salgado-Aranda,Vicente Climent,Laura Padron-Barthe,Iria Duro-Aguado,Juan Jiménez-Jáimez,Víctor M. Hidalgo-Olivares,Enrique García-Campo,Chiara Lanzillo,M. Paz Suárez-Mier,Hagith Yonath,Sonia Marcos-Alonso,Juan Pablo Ochoa,José L. Santomé,Diego García-Giustiniani,Jorge Rodriguez-Garrido,Fernando Dominguez,Marco Merlo,Julián Palomino,Maria Luisa Peña,Juan Pablo Trujillo,Alicia Martín-Vila,Davide Stolfo,Pilar Molina,Enrique Lara-Pezzi,Francisco E. Calvo-Iglesias,Eyal Nof,Leonardo Calò,Roberto Barriales-Villa,Juan Ramón Gimeno-Blanes,Michael Arad,Pablo García-Pavía,Lorenzo Monserrat +35 more
TL;DR: In this article, the authors demonstrate the association between truncating mutations in the Filamin C (FLNC) gene and the development of high-risk dilated and arrhythmogenic cardiomyopathies.
Journal ArticleDOI
Evolving Concepts in Dilated Cardiomyopathy
TL;DR: A comprehensive survey of emerging issues in the clinical management of DCM, including the role of cardiac magnetic resonance for diagnosis and risk categorization and the interaction between genotype and clinical phenotype, and arrhythmic risk stratification.
Journal ArticleDOI
Long‐term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years
Marco Merlo,Alberto Pivetta,Bruno Pinamonti,Davide Stolfo,Massimo Zecchin,Giulia Barbati,Andrea Di Lenarda,Gianfranco Sinagra +7 more
TL;DR: It is shown thatACE‐inhibitors, β‐blockers, implantable cardioverter–defibrillator (ICD) and cardiac resynchronization therapy (CRT) improved prognosis of heart failure.
Journal ArticleDOI
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy
Marta Gigli,Marco Merlo,Sharon L. Graw,Giulia Barbati,Teisha J. Rowland,Dobromir Slavov,Davide Stolfo,Mary E. Haywood,Matteo Dal Ferro,Alessandro Altinier,Federica Ramani,Francesca Brun,Andrea Cocciolo,Ilaria Puggia,Gaetano Morea,William J. McKenna,Francisco G. La Rosa,Matthew R.G. Taylor,Matthew R.G. Taylor,Gianfranco Sinagra,Luisa Mestroni,Luisa Mestroni +21 more
TL;DR: Desmosomal and LMNA gene variants identify the subset of DCM patients who are at greatest risk for SCD and life-threatening ventricular arrhythmias, regardless of the left ventricular ejection fraction.